Dietary Management of Diabetic Chronic Kidney Disease

被引:0
|
作者
Beeharry D. [1 ]
Joseph F. [1 ]
Ewins D. [1 ]
Nair S. [1 ]
机构
[1] Department of Diabetes & Endocrinology, Countess of Chester Hospital NHS Foundation Trust, Countess of Chester Health Park, Liverpool Road, Chester
关键词
Chronic kidney disease; Diabetes mellitus; Diabetic nephropathy; Glomerular filtration rate; Hypertension; Low-protein diet; Low-salt diet; Phosphorus in diet;
D O I
10.1007/s13668-014-0093-3
中图分类号
学科分类号
摘要
Diabetic chronic kidney disease (diabetic nephropathy) is the most common cause for end-stage renal failure and is associated with increased cardiovascular morbidity and mortality. Multiple interventions, including good control of blood pressure, blood glucose, and lipids, have been shown to slow its progression. Dietary management is being considered an adjunct to retard the progression of diabetic nephropathy. Several animal and human studies have evaluated the rationale and potential benefits of using various dietary interventions in patients with diabetic nephropathy. We provide an overview of the current evidence supporting the use of dietary measures in the management of diabetic chronic kidney disease. © 2014, Springer Science+Business Media New York.
引用
收藏
页码:333 / 339
页数:6
相关论文
共 50 条
  • [21] Management of type 2 diabetes in chronic kidney disease
    Triozzi, Jefferson L.
    Parker Gregg, L.
    Virani, Salim S.
    Navaneethan, Sankar D.
    BMJ OPEN DIABETES RESEARCH & CARE, 2021, 9 (01)
  • [22] Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease
    Fernandez-Fernandez, Beatriz
    Mahillo, Ignacio
    Sanchez-Rodriguez, Jinny
    Carriazo, Sol
    Sanz, Ana B.
    Sanchez-Nino, Maria Dolores
    Ortiz, Alberto
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
  • [23] A renaissance in the treatment of diabetic kidney disease, hypertension in chronic kidney disease, and beyond
    Yahr, Jordana
    Calle, Juan
    Taliercio, Jonathan J.
    JOURNAL OF OSTEOPATHIC MEDICINE, 2021, 122 (01): : 55 - 63
  • [24] Role for β-blockers in the management of diabetic kidney disease
    Bakris, GL
    AMERICAN JOURNAL OF HYPERTENSION, 2003, 16 (09) : 7S - 12S
  • [25] The Pathogenesis and Management of Hypertension in Diabetic Kidney Disease
    Van Buren, Peter N.
    Toto, Robert D.
    MEDICAL CLINICS OF NORTH AMERICA, 2013, 97 (01) : 31 - +
  • [26] Update of pathophysiology and management of diabetic kidney disease
    Lin, Yi-Chih
    Chang, Yu-Hsing
    Yang, Shao-Yu
    Wu, Kwan-Dun
    Chu, Tzong-Shinn
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (08) : 662 - 675
  • [27] DIABETIC RETINOPATHY IS A POSSIBLE PROGNOSTIC FACTOR FOR CHRONIC KIDNEY DISEASE PROGRESSION?
    Pantea-Stoian, Anca
    Ditu, Georgiana
    Stefan, Diana Simona
    Purcarea, Victor Lorin
    Serafinceanu, Cristian
    Elian, Viviana
    INTERDIAB 2016: DIABETES MELLITUS AS CARDIOVASCULAR DISEASE, 2016, : 339 - +
  • [28] Clinical management of chronic kidney disease
    Methven, Shona
    MacGregor, Mark S.
    CLINICAL MEDICINE, 2009, 9 (03) : 269 - 272
  • [29] Terpenes in the management of chronic kidney disease
    Kulkarni, Piyusha
    Yeram, Pranali B.
    Vora, Amisha
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (09) : 6351 - 6368
  • [30] Management of Dyslipidemia in Chronic Kidney Disease
    Vedamurthy, Deepak
    Sagheer, Usman
    Patel, Akruti
    Singh, Gurnoor
    Kalra, Dinesh
    CURRENT CARDIOVASCULAR RISK REPORTS, 2025, 19 (01)